David F. Claxton

Also affiliated with Penn State Milton S. Hershey Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 22 papers. Top paper: “Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia”.

Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia

JCO Oncology Practice(2020)10.1200/jop.19.00133

N/A

0.477DataRank · unranked

23 citations

Megan Othus, Guillermo Garcia‐Manero, Min Fang, Jerald P. Radich, David A. Rizzieri +24 more

IMPROVE-BMT: a protocol for a pilot randomised controlled trial of prehabilitation exercise for adult haematopoietic stem cell transplant recipients

BMJ Open(2023)10.1136/bmjopen-2022-066841

N/A

0.451DataRank · unranked

10 citations

KATHRYN H. SCHMITZ, Shin Mineishi, Seema Naik, Baldeep Wirk, Kevin Rakszawski +6 more

A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B‐cell or T‐cell acute lymphoblastic leukemia: Results from the ECOG‐ACRIN EA9152 protocol

eJHaem(2024)10.1002/jha2.991

N/A

0.297DataRank · unranked

5 citations

Ju‐Whei Lee, David F. Claxton, Elisabeth Paietta, Hassan B. Alkhateeb, Jae H. Park +8 more

Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia

Research Square(2021)10.21203/rs.3.rs-506642/v2

N/A

0DataRank · unranked

6 citations

James T. Hagen, Miki Kassai, Li‐Pin Kao, Margaret Nelson, Kelsey McLaughlin +9 more

Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia

Research Square(2021)10.21203/rs.3.rs-506642/v3

N/A

0DataRank · unranked

1 citations

James T. Hagen, Miki Kassai, Li‐Pin Kao, Margaret Nelson, Kelsey McLaughlin +9 more

Alterations in Sphingolipid Composition and Mitochondrial Complex I Deficiency Represent Synergistic Therapeutic Vulnerabilities Linked to Vincristine Resistance

Research Square(2021)10.21203/rs.3.rs-506642/v1

N/A

0DataRank · unranked

0 citations

James T. Hagen, Miki Kassai, Li‐Pin Kao, Margaret Nelson, Kelsey McLaughlin +9 more

Subtype-specific 3D genome alteration in acute myeloid leukaemia

Nature(2022)10.1038/s41586-022-05365-x

N/A

0DataRank · unranked

217 citations

Fan Song, Huijue Lyu, Mikoto Kobayashi, Baozhen Zhang, Ziyu Zhao +24 more

Acute Myeloid Leukemia Stem Cells: Origin, Characteristics, and Clinical Implications

Stem Cell Reviews and Reports(2022)10.1007/s12015-021-10308-6

N/A

0DataRank · unranked

64 citations

Upendarrao Golla, Arati Sharma, David F. Claxton, Nathaniel A. Long

Therapeutic Benefits of Selenium in Hematological Malignancies

International Journal of Molecular Sciences(2022)10.3390/ijms23147972

N/A

0DataRank · unranked

23 citations

Upendarrao Golla, Devnah Trivedi, Shobha Potlakayala, Sairam Rudrabhatla, Dhimant Desai +4 more

Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia

The FASEB Journal(2022)10.1096/fj.202200765r

N/A

0DataRank · unranked

17 citations

Arati Sharma, Tye Deering, Jeremy J.P. Shaw, Pedro Costa‐Pinheiro, Upendarrao Golla +11 more

Interleukin‐4 treatment reduces leukemia burden in acute myeloid leukemia

The FASEB Journal(2022)10.1096/fj.202200251r

N/A

0DataRank · unranked

15 citations

Brooke E. Arner, Kathleen M. Kelly, Charyguly Annageldiyev, Arati Sharma, David F. Claxton +3 more

Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells

Cell Reports(2023)10.1016/j.celrep.2023.112794

N/A

0DataRank · unranked

7 citations

Shaneice K. Nettleford, Jiayan Zhou, Brooke E. Arner, Molly A. Hall, Arati Sharma +13 more

Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute Myeloid Leukemia

Cancers(2023)10.3390/cancers15061883

N/A

0DataRank · unranked

7 citations

Miki Kassai, James T. Hagen, P. Darrell Neufer, Mark Kester, David J. Feith +14 more

Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.21.563437

N/A

0DataRank · unranked

2 citations

Su‐Fern Tan, Todd E. Fox, Jeremy J.P. Shaw, Maansi Taori, Bethany J. Horton +10 more

Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute Myeloid Leukemia

UNC Libraries(2023)10.17615/n1yy-be39

N/A

0DataRank · unranked

0 citations

Jeremy J.P. Shaw, Johnson Ung, Gemma Fabriàs, Miki Kassai, James T. Hagen +14 more

Acute myeloid leukemia stratifies as two clinically relevant sphingolipidomic subtypes

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.13.536805

N/A

0DataRank · unranked

0 citations

Su‐Fern Tan, Todd E. Fox, Johnson Ung, Jeremy J.P. Shaw, Wendy Dunton +14 more

Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes

Blood Advances(2024)10.1182/bloodadvances.2023010535

N/A

0DataRank · unranked

10 citations

Su‐Fern Tan, Todd E. Fox, Johnson Ung, Upendarrao Golla, Jeremy J.P. Shaw +17 more

From Deworming to Cancer Therapy: Benzimidazoles in Hematological Malignancies

Cancers(2024)10.3390/cancers16203454

N/A

0DataRank · unranked

8 citations

Satyam Patel, Nyah Shah, Stella Talamo, Riya Bhalodia, David F. Claxton +3 more

The PI3K/AKT Pathway Inhibitor ISC-4 Induces Apoptosis and Inhibits Growth of Leukemia in Preclinical Models of Acute Myeloid Leukemia

Frontiers in Oncology(2020)10.3389/fonc.2020.00393

N/A

0DataRank · unranked

19 citations

Su‐Fern Tan, Shreya Thakur, Pavan Kumar Dhanyamraju, Srinivasa R. Ramisetti, Preeti Bhadauria +14 more

Acid ceramidase inhibition enhances BCL-2 targeting in venetoclax-resistant acute myeloid leukemia via a cytotoxic integrated stress response

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.06.657881

N/A

0DataRank · unranked

0 citations

Su‐Fern Tan, Jeremy J.P. Shaw, Maansi Taori, Tess M. Deddens, Giovana da Costa Venancio +18 more

NPM1 mutation mediated HOXBLINC lncRNA activation promotes AML leukemogenesis

Research Square(2020)10.21203/rs.3.rs-49109/v1

N/A

0DataRank · unranked

0 citations

Huacheng Luo, Yang Feng, Olga A. Guryanova, Jianfeng Xu, Shi Chen +13 more

HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia

Nature Communications(2021)10.1038/s41467-021-22095-2

N/A

0DataRank · unranked

98 citations

Huacheng Luo, Yang Feng, Olga A. Guryanova, Jianfeng Xu, Shi Chen +16 more